Get more replies from employers
Send a job-specific resume in minutes.
Oxford Biomedica is seeking a VP, Global External Quality to lead the development and execution of our external quality strategy. You will oversee data integrity, supplier quality, and client-facing quality activities across a global network, guiding governance and risk management.
You will join the Global Quality Leadership Team, drive quality transformation, audits, and inspections, and partner with manufacturing and regulatory affairs to ensure GMP compliance and lifecycle quality for
Select how often (in days) to receive an alert:
At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.
We’re currently recruiting for a VP, Global External Quality to join our Global Quality team. In this role, you will lead the development and execution of the Global External Quality strategy, providing oversight across data integrity, external manufacturing partners, suppliers, and client-facing quality activities, playing a key part in advancing our mission and making a real difference.
This role can be located close by one of our global locations in Oxford, UK, or Strasbourg or Lyon in France.
OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.
OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.
We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.